The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
CXCL10 and autoimmune diseases
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis
Strieter, R. M., Polverini, P. J., Kunkel, S. L., Arenberg, D. A., Burdick, M. D., Kasper, J., Dzuiba, J., Van Damme, J., Walz, A., Marriott, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.27348 · Cited by 1,222
Sørensen, T. L., Tani, M., Jensen, J., Pierce, V., Lucchinetti, C., Folcik, V. A., Qin, S., Rottman, J., Sellebjerg, F., Strieter, R. M., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5150 · Cited by 1,002
Taub, D. D., Lloyd, A. R., Conlon, K., Wang, J. M., Ortaldo, J. R., Harada, A., Matsushima, K., Kelvin, D. J., & Oppenheim, J. J. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.6.1809 · Cited by 752
Biochemical characterization of a gamma interferon-inducible cytokine (IP-10).
Luster, A. D., & Ravetch, J. V. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.4.1084 · Cited by 666
Neuropsychiatric syndromes in lupus: Prevalence using standardized definitions
Brey, R. L., Holliday, S. L., Saklad, A. R., Navarrete, M. G., Hermosillo–Romo, D., Stallworth, C. L., Valdez, C. R., Escalante, A., del Rincón, I., Gronseth, G., et al. (2002) · Neurology · doi:10.1212/wnl.58.8.1214 · Cited by 595
Nanki, T., Hayashida, K., El-Gabalawy, H. S., Suson, S., Shi, K., Girschick, H. J., Yavuz, S., & Lipsky, P. E. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6590 · Cited by 455
Critical Roles for Interleukin 1 and Tumor Necrosis Factor α in Antibody-induced Arthritis
Ji, H., Pettit, A., Ohmura, K., Ortiz-Lopez, A., Duchatelle, V., Degott, C., Gravallese, E., Mathis, D., & Benoist, C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020439 · Cited by 332
CXCR3 and CCR5 Ligands in Rheumatoid Arthritis Synovium
Patel, D. D., Zachariah, J. P., & Whichard, L. P. (2001) · Clinical Immunology · doi:10.1006/clim.2000.4957 · Cited by 330
Abe, M., Hiura, K., Wilde, J., Moriyama, K., Hashimoto, T., Ozaki, S., Wakatsuki, S., Kosaka, M., Kido, S., Inoue, D., et al. (2002) · Blood · doi:10.1182/blood.v100.6.2195 · Cited by 294
Role of Chemokines in Endocrine Autoimmune Diseases
Rotondi, M., Chiovato, L., Romagnani, S., Serio, M., & Romagnani, P. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0044 · Cited by 257
Wenzel, J., Wörenkämper, E., Freutel, S., Henze, S., Haller, O., Bieber, T., & Tüting, T. (2005) · The Journal of Pathology · doi:10.1002/path.1721 · Cited by 247
WRIGHT, L., MALONEY, W., YU, X., KINDLE, L., COLLINOSDOBY, P., & OSDOBY, P. (2005) · Bone · doi:10.1016/j.bone.2005.01.021 · Cited by 232
HASEGAWA, M., SATO, S., & TAKEHARA, K. (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1999.00929.x · Cited by 208
Interleukin‐6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus
Fragoso‐Loyo, H., Richaud‐Patin, Y., Orozco‐Narváez, A., Dávila‐Maldonado, L., Atisha‐Fregoso, Y., Llorente, L., & Sánchez‐Guerrero, J. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22451 · Cited by 184
Lit, L. C. W., Wong, C. K., Tam, L. S., Li, E. K. M., & Lam, C. W. K. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.038315 · Cited by 181
García-López, M. Á., Sánchez-Madrid, F., Rodríguez-Frade, J. M., Mellado, M., Acevedo, A., García, M. I., Albar, J. P., Martínez-A, C., & Marazuela, M. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780248 · Cited by 169
Jinquan, T., Jing, C., Jacobi, H. H., Reimert, C. M., Millner, A., Quan, S., Hansen, J. B., Dissing, S., Malling, H.-J., Skov, P. S., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.3.1548 · Cited by 169
Kwak, H. B., Ha, H., Kim, H., Lee, J.-H., Kim, H. S., Lee, S., Kim, H., Kim, J. Y., Kim, H., Song, Y. W., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23372 · Cited by 141
Self-citationHanaoka, R., Kasama, T., Muramatsu, M., Yajima, N., Shiozawa, F., Miwa, Y., Negishi, M., Ide, H., Miyaoka, H., Uchida, H., et al. (2003) · Arthritis Research & Therapy · doi:10.1186/ar616 · Cited by 141
Decreased Th1-like and Increased Th2-like Cells in Systemic Lupus Erythematosus
Funauchi, M. (1998) · Scandinavian Journal of Rheumatology · doi:10.1080/030097498440859 · Cited by 134
SERUM LEVELS OF IFN-INDUCIBLE PROTEIN-10 RELATING TO THE ACTIVITY OF SYSTEMIC LUPUS ERYTHEMATOSUS
Narumi, S., Takeuchi, T., Kobayashi, Y., & Konishi, K. (2000) · Cytokine · doi:10.1006/cyto.2000.0757 · Cited by 126
CXCL10 ( ) and CCL2 ( ) chemokines in systemic sclerosis a longitudinal study
Antonelli, A., Ferri, C., Fallahi, P., Ferrari, S. M., Giuggioli, D., Colaci, M., Manfredi, A., Frascerra, S., Franzoni, F., Galetta, F., et al. (2007) · Rheumatology · doi:10.1093/rheumatology/kem313 · Cited by 123
Prud’homme, G. J., Kono, D. H., & Theofilopoulos, A. N. (1995) · Molecular Immunology · doi:10.1016/0161-5890(95)00024-9 · Cited by 116
Tsubaki, T., Takegawa, S., Hanamoto, H., et al. (2005) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02850.x · Cited by 100
Fujii, H., Shimada, Y., Hasegawa, M., Takehara, K., & Sato, S. (2004) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2004.03.001 · Cited by 89
Inhibition of CX3CL1 (Fractalkine) Improves Experimental Autoimmune Myositis in SJL/J Mice
Suzuki, F., Nanki, T., Imai, T., Kikuchi, H., Hirohata, S., Kohsaka, H., & Miyasaka, N. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6987 · Cited by 66
Fall, N., Bove, K. E., Stringer, K. F., Lovell, D. J., Brunner, H. I., Weiss, J. E., Higgins, G. C., Bowyer, S. L., Graham, T. B., Thornton, S., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21303 · Cited by 63
Alpha-chemokine receptors CXCR1–3 and their ligands in idiopathic inflammatory myopathies
Paepe, B. D., Keyzer, K. D., Martin, J., & Bleecker, J. D. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-0989-5 · Cited by 60
Hasegawa, H., Inoue, A., Kohno, M., Muraoka, M., Miyazaki, T., Terada, M., Nakayama, T., Yoshie, O., Nose, M., & Yasukawa, M. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21745 · Cited by 58
T-cell involvement in osteoclast biology: implications for rheumatoid bone erosion
O’Gradaigh, D., & Compston, J. E. (2003) · Rheumatology · doi:10.1093/rheumatology/keg447 · Cited by 38
Romas (2000) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200004)43:4
Komuro (2001) · doi:10.1002/1529-0131(200112)44:12
Cited by
Kaul, A., Gordon, C., Crow, M. K., Touma, Z., Urowitz, M. B., van Vollenhoven, R., Ruiz-Irastorza, G., & Hughes, G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.39 · Cited by 1,391
Antonelli, A., Ferrari, S. M., Corrado, A., Di Domenicantonio, A., & Fallahi, P. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.10.016 · Cited by 925
Chemokine (C–X–C motif) ligand (CXCL)10 in autoimmune diseases
Antonelli, A., Ferrari, S. M., Giuggioli, D., Ferrannini, E., Ferri, C., & Fallahi, P. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.10.010 · Cited by 595
“Recent reports have shown that the serum and/or the tissue expressions of CXCL10 are increased in organ specific autoimmune diseases, such as autoimmune thyroiditis (AT), Graves' disease (GD), and type 1 diabetes (T1D) [3], or systemic rheumatological disorders like rheumatoid arthritis (RA), systemic lupus erythemato…”
BackgroundThe emerging role of CXCL10 in cancer (Review)
LIU, M., GUO, S., & STILES, J. K. (2011) · Oncology Letters · doi:10.3892/ol.2011.300 · Cited by 411
Liu, Y., Ramot, Y., Torrelo, A., Paller, A. S., Si, N., Babay, S., Kim, P. W., Sheikh, A., Lee, C. R., Chen, Y., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33368 · Cited by 406
Metadata
- Authors
- Lee, E. Y., Lee, Z.-H., & Song, Y. W.
- Venue
- Autoimmunity Reviews
- Publisher
- Elsevier BV
- Published
- 2009-03
- Volume
- 8
- Issue
- 5
- Pages
- 379-383
- ISSN
- 1568-9972 (ISSN-L)
- OpenAlex
- W1992489519
- Cited by
- 357
- References
- 33
- FWCI
- 6.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.